Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-09-11 14:11:37 UTC
Update Date2021-09-26 23:08:58 UTC
HMDB IDHMDB0254750
Secondary Accession NumbersNone
Metabolite Identification
Common NameMirodenafil
DescriptionMirodenafil belongs to the class of organic compounds known as benzenesulfonamides. These are organic compounds containing a sulfonamide group that is S-linked to a benzene ring. Mirodenafil belongs to the drug class PDE5 inhibitors, which includes avanafil, sildenafil, tadalafil, udenafil, and vardenafil, and is the first-line treatment for erectile dysfunction. Mirodenafil is a very strong basic compound (based on its pKa). Several clinical trials were conducted, but mirodenafil has not been approved for use in the United States by the U.S. Food and Drug Administration. Developed by SK Chemicals Life Science, mirodenafil is marketed in Korea under the trade name Mvix, offered both as tablets (50 mg and 100 mg) and as orally dissolving film (50 mg). This compound has been identified in human blood as reported by (PMID: 31557052 ). Mirodenafil is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Mirodenafil is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
Synonyms
ValueSource
5-Ethyl-2-(5-(4-(2-hydroxyethyl)piperazine-1-sulfonyl)-2-propoxyphenyl)-7-propyl-3,5-dihydro-4H-pyrrolo(3,2-D)pyrimidin-4-oneMeSH
5-Ethyl-2-(5-{[4-(2-hydroxyethyl)piperazin-1-yl]sulphonyl}-2-propoxyphenyl)-7-propyl-5H-pyrrolo[3,2-D]pyrimidin-4-olGenerator
Chemical FormulaC26H37N5O5S
Average Molecular Weight531.67
Monoisotopic Molecular Weight531.251540485
IUPAC Name5-ethyl-2-(5-{[4-(2-hydroxyethyl)piperazin-1-yl]sulfonyl}-2-propoxyphenyl)-7-propyl-3H,4H,5H-pyrrolo[3,2-d]pyrimidin-4-one
Traditional Namemirodenafil
CAS Registry NumberNot Available
SMILES
CCCOC1=CC=C(C=C1C1=NC2=C(N(CC)C=C2CCC)C(=O)N1)S(=O)(=O)N1CCN(CCO)CC1
InChI Identifier
InChI=1S/C26H37N5O5S/c1-4-7-19-18-30(6-3)24-23(19)27-25(28-26(24)33)21-17-20(8-9-22(21)36-16-5-2)37(34,35)31-12-10-29(11-13-31)14-15-32/h8-9,17-18,32H,4-7,10-16H2,1-3H3,(H,27,28,33)
InChI KeyMIJFNYMSCFYZNY-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as benzenesulfonamides. These are organic compounds containing a sulfonamide group that is S-linked to a benzene ring.
KingdomOrganic compounds
Super ClassBenzenoids
ClassBenzene and substituted derivatives
Sub ClassBenzenesulfonamides
Direct ParentBenzenesulfonamides
Alternative Parents
Substituents
  • Benzenesulfonamide
  • Benzenesulfonyl group
  • Pyrrolopyrimidine
  • Phenoxy compound
  • Phenol ether
  • Pyrimidone
  • Alkyl aryl ether
  • N-alkylpiperazine
  • 1,4-diazinane
  • Piperazine
  • Pyrimidine
  • Substituted pyrrole
  • Organosulfonic acid amide
  • Pyrrole
  • Heteroaromatic compound
  • Vinylogous amide
  • Sulfonyl
  • Organosulfonic acid or derivatives
  • Organic sulfonic acid or derivatives
  • Tertiary aliphatic amine
  • 1,2-aminoalcohol
  • Tertiary amine
  • Alkanolamine
  • Ether
  • Azacycle
  • Organoheterocyclic compound
  • Organosulfur compound
  • Organooxygen compound
  • Organonitrogen compound
  • Alcohol
  • Organic oxide
  • Organopnictogen compound
  • Amine
  • Hydrocarbon derivative
  • Organic nitrogen compound
  • Primary alcohol
  • Organic oxygen compound
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP2.85ALOGPS
logP2.44ChemAxon
logS-3.5ALOGPS
pKa (Strongest Acidic)7.69ChemAxon
pKa (Strongest Basic)5.83ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count7ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area116.47 ŲChemAxon
Rotatable Bond Count10ChemAxon
Refractivity146.61 m³·mol⁻¹ChemAxon
Polarizability57.75 ųChemAxon
Number of Rings4ChemAxon
BioavailabilityYesChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M+H]+226.030932474
DeepCCS[M-H]-223.60530932474
DeepCCS[M-2H]-256.4930932474
DeepCCS[M+Na]+232.26430932474
AllCCS[M+H]+220.832859911
AllCCS[M+H-H2O]+219.332859911
AllCCS[M+NH4]+222.232859911
AllCCS[M+Na]+222.632859911
AllCCS[M-H]-210.332859911
AllCCS[M+Na-2H]-212.232859911
AllCCS[M+HCOO]-214.432859911

Predicted Retention Times

Underivatized

Chromatographic MethodRetention TimeReference
Predicted by Siyang on May 30, 202212.3116 minutes33406817
Predicted by Siyang using ReTip algorithm on June 8, 20222.89 minutes32390414
Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid1839.5 seconds40023050
Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid172.1 seconds40023050
Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid191.0 seconds40023050
Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid163.9 seconds40023050
RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid102.1 seconds40023050
Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid523.0 seconds40023050
BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid527.6 seconds40023050
HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate)175.6 seconds40023050
UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid973.8 seconds40023050
BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid476.4 seconds40023050
UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid1645.8 seconds40023050
SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid333.8 seconds40023050
RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid362.9 seconds40023050
MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate287.9 seconds40023050
KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA237.3 seconds40023050
Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water10.6 seconds40023050

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
MirodenafilCCCOC1=CC=C(C=C1C1=NC2=C(N(CC)C=C2CCC)C(=O)N1)S(=O)(=O)N1CCN(CCO)CC15681.9Standard polar33892256
MirodenafilCCCOC1=CC=C(C=C1C1=NC2=C(N(CC)C=C2CCC)C(=O)N1)S(=O)(=O)N1CCN(CCO)CC14140.7Standard non polar33892256
MirodenafilCCCOC1=CC=C(C=C1C1=NC2=C(N(CC)C=C2CCC)C(=O)N1)S(=O)(=O)N1CCN(CCO)CC14704.7Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Mirodenafil,2TMS,isomer #1CCCOC1=CC=C(S(=O)(=O)N2CCN(CCO[Si](C)(C)C)CC2)C=C1C1=NC2=C(C(=O)N1[Si](C)(C)C)N(CC)C=C2CCC4226.8Semi standard non polar33892256
Mirodenafil,2TMS,isomer #1CCCOC1=CC=C(S(=O)(=O)N2CCN(CCO[Si](C)(C)C)CC2)C=C1C1=NC2=C(C(=O)N1[Si](C)(C)C)N(CC)C=C2CCC4396.0Standard non polar33892256
Mirodenafil,2TMS,isomer #1CCCOC1=CC=C(S(=O)(=O)N2CCN(CCO[Si](C)(C)C)CC2)C=C1C1=NC2=C(C(=O)N1[Si](C)(C)C)N(CC)C=C2CCC5795.4Standard polar33892256
Mirodenafil,2TBDMS,isomer #1CCCOC1=CC=C(S(=O)(=O)N2CCN(CCO[Si](C)(C)C(C)(C)C)CC2)C=C1C1=NC2=C(C(=O)N1[Si](C)(C)C(C)(C)C)N(CC)C=C2CCC4569.3Semi standard non polar33892256
Mirodenafil,2TBDMS,isomer #1CCCOC1=CC=C(S(=O)(=O)N2CCN(CCO[Si](C)(C)C(C)(C)C)CC2)C=C1C1=NC2=C(C(=O)N1[Si](C)(C)C(C)(C)C)N(CC)C=C2CCC4886.2Standard non polar33892256
Mirodenafil,2TBDMS,isomer #1CCCOC1=CC=C(S(=O)(=O)N2CCN(CCO[Si](C)(C)C(C)(C)C)CC2)C=C1C1=NC2=C(C(=O)N1[Si](C)(C)C(C)(C)C)N(CC)C=C2CCC5689.0Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - Mirodenafil GC-MS (TMS_1_1) - 70eV, PositiveNot Available2021-11-04Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Mirodenafil GC-MS (TMS_1_2) - 70eV, PositiveNot Available2021-11-04Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Mirodenafil GC-MS (TBDMS_1_1) - 70eV, PositiveNot Available2021-11-04Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Mirodenafil GC-MS (TBDMS_1_2) - 70eV, PositiveNot Available2021-11-04Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Mirodenafil 10V, Positive-QTOFsplash10-001i-0001290000-f040ff7380f091548dc62017-07-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Mirodenafil 20V, Positive-QTOFsplash10-03du-6604970000-ed75101661d9235e2d432017-07-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Mirodenafil 40V, Positive-QTOFsplash10-0006-9131010000-0fab5ad5c2bd1da1ee3d2017-07-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Mirodenafil 10V, Negative-QTOFsplash10-001i-0000490000-6d268f705ddfd9d18c0a2017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Mirodenafil 20V, Negative-QTOFsplash10-0flc-0200940000-d75ac7ef48b621e44b8a2017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Mirodenafil 40V, Negative-QTOFsplash10-01ox-3905500000-4fa6ac016892f592417f2017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Mirodenafil 10V, Positive-QTOFsplash10-001i-0000090000-7ac7e3b89177e028d9fb2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Mirodenafil 20V, Positive-QTOFsplash10-0006-0001920000-9d598fd8f254deeb4b6a2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Mirodenafil 40V, Positive-QTOFsplash10-03di-3401910000-27a6c817cf6f3627a9d82021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Mirodenafil 10V, Negative-QTOFsplash10-001i-0000190000-a8579751e49d6b8ec6282021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Mirodenafil 20V, Negative-QTOFsplash10-0a4r-0000920000-50d4d0848628e4bebe792021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Mirodenafil 40V, Negative-QTOFsplash10-08fr-0010900000-5c6f3ce4a1543ebbeeb52021-10-12Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDDB11792
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider IDNot Available
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkMirodenafil
METLIN IDNot Available
PubChem Compound12001014
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]